Why this ASX 200 healthcare share price is up 350% in 1 year

Shares in ASX 200 healthcare company Avita Medical Ltd (ASX: AVH) have surged higher in the last 12 months – but are they in the buy zone?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in ASX 200 healthcare group Avita Medical Ltd (ASX: AVH) have had an impressive run in the last 12 months. In the past year, the medical tech group's shares are up 353.57% higher to $0.64 per share. That means Avita's market capitalisation has rocketed to $1.34 billion and pushed it inside the S&P/ASX 200 Index (INDEXASX: XJO).

But, what's driving the ASX 200 healthcare group's shares higher right now and is there still time to buy?

Why Avita Medical shares have rocketed in the last 12 months

Let's start with some background on what exactly Avita does. The ASX 200 healthcare group specialises in regenerative medicine headlined by its ReCell spray-on skin for the treatment of burns. Over the past 20 years, Avita has been working to develop its flagship product which is FDA approved in the USA for the treatment of acute thermal burn wounds.

Medical professionals around the world have successfully used the ReCell product more than 8,000 times with studies showing a 97.5% reduction in skin donation requirements for second-degree burns, and a 32% reduction for third-degree. The ASX 200 healthcare group is also researching whether the product can be used to treat paediatric scalds and soft tissue reconstruction by the end of Q1 2020.

The Avita share price has ridden this product expansion right to the top. The group's shares are up more than 350% in the last year and nearly 700% since the start of 2019.

Should you buy into the ASX 200 healthcare group?

I think it's easy to look at an ASX 200 growth company like Avita and think you've missed the boat. And in all honesty, there is a chance that the growth potential has gone already.

However, if you took the same approach with CSL Limited (ASX: CSL) you would have been wrong many times over. The CSL share price is up more than 40,000% from its split-adjusted IPO price of $0.76 per share.

If you're risk-averse, then maybe buying Avita Medical shares isn't for you. However, with strong product results and the tick of approval from medical professionals, I think shares in this ASX 200 healthcare company could go higher in 2020 and beyond.

Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Avita Medical Limited and CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

Guess which ASX All Ords stock is jumping on big US news

This small cap is catching the eye on Thursday. But why?

Read more »

three excited doctors with hands in the air
Healthcare Shares

Two ASX healthcare shares that could be set to double

This broker has buy recommendations on these two shares. 

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Telix shares jump 7% on big US news

Let's see what is getting investors excited on Wednesday.

Read more »

An older gentleman leans over his partner's shoulder as she looks at a tablet device while seated at a table.
Healthcare Shares

Macquarie tips 28% upside for this ASX healthcare stock

The broker expects big things from this New Zealand retirement village developer and operator.

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

$10,000 invested in these ASX healthcare shares 5 years ago is now worth…

These healthcare stocks have brought big returns for investors 

Read more »

A man wearing a white coat and glasses is wide-mouthed in surprise.
Healthcare Shares

Guess which ASX 300 stock is crashing 55% today

What's going on with this stock? Let's see why investors are hitting the sell button.

Read more »

Woman serving customer in pharmacy.
Healthcare Shares

Up 132% in a year, are Sigma Healthcare shares still a good buy post the Chemist Warehouse merger?

After gaining 132% in 12 months, it too late to buy Sigma Healthcare shares today?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Share Market News

Is it too late to buy Pro Medicus shares?

Pro Medicus shares have risen 550% over 3 years. Have you missed the boat? Three experts weigh in.

Read more »